Drug Pricing Reform In Medicare And Medicaid: Upcoming Regulatory Actions

Two highly anticipated proposed rules in Medicare Part D are scheduled for near-term release.

Dollar sign made with drug pills

HHS lists upcoming regulatory action covering actions in Medicare and Medicaid aimed at lowering drugs prices in its unified agenda, released Oct. 17. The following is a summary of some key upcoming rules:

What: HHS Office of Inspector General proposed rule titled, “Removal of Safe Harbor Protection for Rebates to Plans or PBMs...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access